Health & Medical Archives | Be Korea-savvy

Archive by category Health & Medical

Philips Extends Leadership in Virtually Helium-free MRI with More Than 1,000 Systems Installed, Expanding Patient Access Worldwide

Philips Extends Leadership in Virtually Helium-free MRI with More Than 1,000 Systems Installed, Expanding Patient Access Worldwide

February 28, 2024 (Korea Bizwire) At #ECR2024, company also debuting Europe’s first mobile virtually helium-free MRI system Amsterdam, the Netherlands and Vienna, Austria – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced a significant milestone as it expands access to virtually helium-free [1] MRI to more patients in more places, with more [...]

Novotech Publishes Duchenne Muscular Dystrophy Landscape Report to Support Biotech Research Planning

Novotech Publishes Duchenne Muscular Dystrophy Landscape Report to Support Biotech Research Planning

BOSTON, Feb. 28, 2024 (Korea Bizwire) – Novotech, the global full-service clinical Contract Research Organization (CRO) that partners with biotech companies to accelerate the development of advanced and novel therapeutics at every phase, has released today an industry-leading report on Duchenne Muscular Dystrophy (DMD) Clinical Trial Landscape. The report includes emerging genetic therapies, funding landscape, and a [...]

Charlotte Hanneman to succeed Abhijit Bhattacharya as Philips’ Chief Financial Officer (CFO)

Charlotte Hanneman to succeed Abhijit Bhattacharya as Philips’ Chief Financial Officer (CFO)

February 28, 2024 (Korea Bizwire) Proposal to appoint Ms. Hanneman as member of Philips’ Board of Management fulfilling the role of CFO per October 1, 2024 Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the proposal to appoint Charlotte Hanneman as member of the Board of Management, [...]

Philips Launches New Azurion Neuro Biplane System at #ECR2024 to Speed Up and Improve Minimally Invasive Diagnosis and Treatment of Neurovascular Patients

Philips Launches New Azurion Neuro Biplane System at #ECR2024 to Speed Up and Improve Minimally Invasive Diagnosis and Treatment of Neurovascular Patients

February 27, 2024 (Korea Bizwire) New image-guided therapy system is a complete interventional solution for confident diagnosis, image guidance, and therapy assessment of patients with stroke or other neurovascular diseases Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced major enhancements to its Image Guided Therapy System – [...]

Zymeworks Announces Participation in Upcoming Investor Conferences

Zymeworks Announces Participation in Upcoming Investor Conferences

VANCOUVER, British Columbia, Feb. 27, 2024 (Korea Bizwire) – Zymeworks Inc. (Nasdaq: ZYME), a clinical-stage biotechnology company developing a diverse pipeline of novel, multifunctional biotherapeutics to improve the standard of care for difficult-to-treat diseases, today announced that management will participate in the following upcoming investor conferences: TD Cowen 44th Annual Health Care Conference: Zymeworks’ management will [...]

Telesis Bio Announces Select Preliminary Fourth Quarter 2023 Financial Results

Telesis Bio Announces Select Preliminary Fourth Quarter 2023 Financial Results

Telesis Bio announces Q4 and full-year 2023 select preliminary financial results, highlighting strong BioXp kit sales, expanding gross margin and reduced expense SAN DIEGO, Feb. 26, 2024 (Korea Bizwire) – Telesis Bio Inc. (NASDAQ: TBIO), a leading provider of RNA and DNA solutions enabling researchers to accelerate therapeutic discovery through advanced, flexible and rapid automated [...]

Survodutide Phase II Trial Shows 83% of Adults Treated Achieved Groundbreaking Results in Liver Disease Due to MASH, with Significant Improvements in Fibrosis

Survodutide Phase II Trial Shows 83% of Adults Treated Achieved Groundbreaking Results in Liver Disease Due to MASH, with Significant Improvements in Fibrosis

Survodutide has potential to become best-in-class treatment for metabolic dysfunction-associated steatohepatitis (MASH)*, after meeting its primary and key secondary endpoint following 48 weeks of treatment versus placebo in a Phase II trial Survodutide, a novel glucagon/GLP-1 receptor dual agonist, has demonstrated efficacy in people with obesity1, and statistically significant results in MASH2 suggest the potential to [...]

Curia Appoints Steve Lavezoli as Vice President, Biologics

Curia Appoints Steve Lavezoli as Vice President, Biologics

ALBANY, N.Y., Feb. 23, 2024 (Korea Bizwire) – Curia, a leading contract research, development and manufacturing organization, today announced it has appointed Steve Lavezoli as vice president of biologics effective Feb. 26. Lavezoli will lead Curia’s biologics division, overseeing its discovery, development and manufacturing services. “This is an exciting time for our biologics team, and [...]

Malaysia: Redefining Cancer Treatment Standards

Malaysia: Redefining Cancer Treatment Standards

Embark on a Journey of Cutting-Edge Treatments and Research Collaboration KUALA LUMPUR, Malaysia, Feb. 21 (Korea Bizwire) — As the world marks Cancer Awareness Month, Malaysia has made significant strides in the field of cancer treatment, earning recognition as a premier destination for individuals seeking advanced care. With its state-of-the-art medical facilities, renowned healthcare professionals, [...]

Philips Delivers Strong ESG Performance in 2023

Philips Delivers Strong ESG Performance in 2023

February 20, 2024 (Korea Bizwire) 1.88 billion lives improved by Philips’ health technology products and services; on track to improve 2 billion lives by 2025 Through its industry leading innovations and partnerships, Philips helps increase access to healthcare globally and create sustainable and resilient healthcare models Philips expanded its circular revenues to 20% of sales; remained [...]